165 related articles for article (PubMed ID: 1419353)
1. [Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas].
Sanno N; Teramoto A; Inada K; Osamura Y
No To Shinkei; 1992 Aug; 44(8):745-53. PubMed ID: 1419353
[TBL] [Abstract][Full Text] [Related]
2. Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.
Katznelson L; Alexander JM; Bikkal HA; Jameson JL; Hsu DW; Klibanski A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1343-51. PubMed ID: 1375599
[TBL] [Abstract][Full Text] [Related]
3. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
[TBL] [Abstract][Full Text] [Related]
4. Gonadotroph cell pituitary adenomas.
Snyder PJ
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
[TBL] [Abstract][Full Text] [Related]
5. Recognition of gonadotroph adenomas in women.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
[TBL] [Abstract][Full Text] [Related]
6. Effects of salmon gonadotropin-releasing hormone on follicle stimulating hormone secretion and subunit gene expression in coho salmon (Oncorhynchus kisutch).
Dickey JT; Swanson P
Gen Comp Endocrinol; 2000 Jun; 118(3):436-49. PubMed ID: 10843795
[TBL] [Abstract][Full Text] [Related]
7. Gonadotroph cell adenomas of the pituitary.
Snyder PJ
Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
[TBL] [Abstract][Full Text] [Related]
8. Analysis of secretory, immunostaining and clinical characteristics of human "functionless" pituitary adenomas: transdifferentiation or gonadotropinomas?
de Oliveira Machado AL; Adams EF; Schott W; Nomikos P; Fahlbusch R; Buchfelder M
Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):344-9. PubMed ID: 15977103
[TBL] [Abstract][Full Text] [Related]
9. Non-functioning pituitary adenomas.
Chanson P; Brochier S
J Endocrinol Invest; 2005; 28(11 Suppl International):93-9. PubMed ID: 16625856
[TBL] [Abstract][Full Text] [Related]
10. Alpha-subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly.
Kontogeorgos G; Kovacs K; Scheithauer BW; Rologis D; Orphanidis G
Mod Pathol; 1991 Mar; 4(2):191-5. PubMed ID: 1646455
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas.
Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV
J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538
[TBL] [Abstract][Full Text] [Related]
12. Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomas.
Kwekkeboom DJ; de Jong FH; Lamberts SW
J Steroid Biochem; 1989 Oct; 33(4B):777-82. PubMed ID: 2513452
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.
Snyder PJ; Muzyka R; Johnson J; Utiger RD
J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992
[TBL] [Abstract][Full Text] [Related]
14. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
16. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
[TBL] [Abstract][Full Text] [Related]
17. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas.
Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY
Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926
[TBL] [Abstract][Full Text] [Related]
18. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors.
Trouillas J; Girod C; Sassolas G; Claustrat B
Semin Diagn Pathol; 1986 Feb; 3(1):42-57. PubMed ID: 3112888
[TBL] [Abstract][Full Text] [Related]
19. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma.
Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K
Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232
[TBL] [Abstract][Full Text] [Related]
20. Effect of LHRH on plasma 7B2 in patients with gonadotropin-producing pituitary adenomas.
Iguchi H; Demura R; Yasuda D; Wakasugi H
Horm Metab Res; 1992 Jan; 24(1):31-3. PubMed ID: 1612556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]